PCV 20: Clinical Trials

3 trials of PCV 20, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Recruiting 2, Completed 1

Follow PCV 20: new trials by email Literature Review of PCV 20 trials Research Report on PCV 20

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine
IVT PCV-25 Formulation A, IVT PCV-25 Formulation B, IVT PCV-25 Formulation C - Pneumococcal Vaccines
Phase 2CompletedInventprise Inc.2202023-10-252026-03-17
Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia
Pneumococcal 20-valent Conjugate Vaccine, Pneumococcal Polyvalent Vaccine - Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 2RecruitingSeema Bhat802023-09-292026-01-07
Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial
Pneumococcal 20-valent Conjugate Vaccine, Pneumococcal Polyvalent Vaccine - Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 2RecruitingUniversity of Utah612022-01-312026-04-09

Conditions studied

Leukemia, Lymphocytic, Chronic, B-Cell (2)

Sponsors

Inventprise Inc. (1)  ·  Seema Bhat (1)  ·  University of Utah (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Daniel Ermann, MD (1)  ·  Seema A Bhat, MD (1)  ·  Sybil Tasker, MD, MPH, FIDSA (1)

Results publications

PMID 40396505, PMID 41576705